SEC Form 4 · accession 0001225208-18-002429
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard R. DeLuca
Officer — EVP&Pres, Merck Animal Health
Period of report
Feb 9, 2018
Accepted (ET)
Feb 9, 2018 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2018 | M | 8,572 | $0.00 | A | 45,780 | D | |
| Common StockF1 | Feb 9, 2018 | F | 2,974 | $54.73 | D | 42,806 | D | |
| Common Stock - 401(k) PlanF2 | holding | — | — | — | 1,038 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3 | — | Feb 9, 2018 | M | 8,572 | D | Feb 9, 2018 | Feb 9, 2018 | Common Stock | 8,572 | 0 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2Includes shares acquired and dividends earned through January 8, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.
- F3Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
Remarks
delucapoa.txt